Phong Phu Pharmaceutical JSC (HNX:PPP)
18,800
+400 (2.17%)
At close: Apr 28, 2026
HNX:PPP Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 166,320 | 180,400 | 155,760 | 130,240 | 113,520 | 154,880 | Upgrade
|
| Market Cap Growth | 11.18% | 15.82% | 19.60% | 14.73% | -26.71% | 55.75% | Upgrade
|
| Enterprise Value | 122,983 | 148,925 | 127,715 | 102,957 | 98,639 | 155,753 | Upgrade
|
| Last Close Price | 18900.00 | 19000.00 | 15116.54 | 11845.69 | 9333.44 | 11880.29 | Upgrade
|
| PE Ratio | 10.04 | 10.89 | 10.02 | 7.18 | 5.51 | 9.17 | Upgrade
|
| PS Ratio | 1.19 | 1.29 | 1.13 | 0.86 | 0.75 | 1.16 | Upgrade
|
| PB Ratio | 1.20 | 1.30 | 1.15 | 1.00 | 0.91 | 1.33 | Upgrade
|
| P/TBV Ratio | 1.36 | 1.47 | 1.31 | 1.15 | 1.07 | 1.59 | Upgrade
|
| P/FCF Ratio | 10.89 | 11.81 | 9.28 | 7.47 | 5.64 | 8.54 | Upgrade
|
| P/OCF Ratio | 9.90 | 10.74 | 8.99 | 5.91 | 5.42 | 8.03 | Upgrade
|
| EV/Sales Ratio | 0.88 | 1.07 | 0.93 | 0.68 | 0.66 | 1.17 | Upgrade
|
| EV/EBITDA Ratio | 4.85 | 5.88 | 5.22 | 3.69 | 3.14 | 6.02 | Upgrade
|
| EV/EBIT Ratio | 5.80 | 7.03 | 6.31 | 4.46 | 3.92 | 7.91 | Upgrade
|
| EV/FCF Ratio | 8.05 | 9.75 | 7.61 | 5.91 | 4.90 | 8.59 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | - | - | - | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.25 | 0.25 | - | - | - | 0.08 | Upgrade
|
| Debt / FCF Ratio | 0.41 | 0.41 | - | - | - | 0.11 | Upgrade
|
| Net Debt / Equity Ratio | -0.31 | -0.31 | -0.29 | -0.25 | -0.21 | -0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.71 | -1.71 | -1.63 | -1.15 | -0.84 | -0.62 | Upgrade
|
| Net Debt / FCF Ratio | -2.84 | -2.84 | -2.38 | -1.84 | -1.31 | -0.89 | Upgrade
|
| Asset Turnover | 0.81 | 0.81 | 0.84 | 0.96 | 0.96 | 0.89 | Upgrade
|
| Inventory Turnover | 2.35 | 2.35 | 2.65 | 3.00 | 2.54 | 2.31 | Upgrade
|
| Quick Ratio | 1.54 | 1.54 | 1.64 | 1.57 | 1.21 | 0.74 | Upgrade
|
| Current Ratio | 2.66 | 2.66 | 2.89 | 2.71 | 2.35 | 1.80 | Upgrade
|
| Return on Equity (ROE) | 13.54% | 13.54% | 13.06% | 15.77% | 17.09% | 15.07% | Upgrade
|
| Return on Assets (ROA) | 7.71% | 7.71% | 7.74% | 9.08% | 10.02% | 8.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.23% | 17.21% | 16.65% | 19.22% | 20.25% | 16.28% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.30% | 15.30% | 14.90% | 17.70% | 20.20% | 16.90% | Upgrade
|
| Earnings Yield | 9.96% | 10.29% | 11.14% | 15.43% | 18.16% | 10.91% | Upgrade
|
| FCF Yield | 9.18% | 8.47% | 10.78% | 13.38% | 17.72% | 11.71% | Upgrade
|
| Dividend Yield | 7.98% | - | 9.92% | 10.13% | 15.00% | - | Upgrade
|
| Payout Ratio | 71.28% | 71.28% | 60.16% | 62.02% | 50.08% | 35.37% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | 9.83% | 0.34% | 0.72% | Upgrade
|
| Total Shareholder Return | 8.15% | - | 9.92% | 19.96% | 15.35% | 0.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.